Latest news
IPO News - US IPO Weekly Recap: August kicks off with flurry of biotech IPOs - renaissancecapital.comrenaissancecapital.com · Fri, 07 Aug 2026 22:26:43 GMTGate Pre-IPOs Phase 3 Launches Moonshot AI (KIMI), Supporting Subscription with USDT and GUSD - BeInCryptoBeInCrypto · Thu, 06 Aug 2026 12:59:00 GMTUpdated: Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3 - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 06:56:00 GMTAttovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 10:58:58 GMTAGIBOT Adjusts Core Management During Critical IPO Phase - GasgooGasgoo · Wed, 05 Aug 2026 06:39:11 GMTLatigo, BlossomHill detail IPO plans for pain and cancer push - biospace.combiospace.com · Tue, 04 Aug 2026 07:00:00 GMTPfizer’s Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182M - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 15:16:00 GMT